← Leaderboards
Heidi Reesink
Cornell University
$1,180,170
Attributed
$1,180,170
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $205.4K · FY2017–23$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,180,170 · 2
By mechanism
K08$1,023,170 · 1
R03$157,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Cornell University
Same institution · by research overlap
- Michelle Lee Delco$1,000,730
- Lauren Virginia Schnabel$1,774,289
- Margaret Mary Brosnahan$516,632
- David A Putnam$6,433,806
- Matthew J Paszek$6,262,935
Others in their field
Other Emerging Leaders on “Gene Expression”
- Evan Z Macosko · Broad Institute, Inc.$35,121,158
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Benjamin E Deverman · Broad Institute, Inc.$16,920,984
- Tomasz Nowakowski · University Of California, San Francisco$15,628,426
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Crystal Mackall · Children'S Hosp Of Philadelphia$14,040,300
Research focus
Gene ExpressionAttenuatedIn VitroGlycoproteinsPropertyOrthopedicsMucinsDisciplineLubricinIn VivoPolysaccharidesPreventRecombinantsSynovial FluidClinically RelevantEquus CaballusDesignBiocompatible MaterialsGlycosylationBaseDegenerative PolyarthritisCarbohydrate StructureAgingCareer
Grant awards (8)
Engineering recombinant lubricin to combat orthopedic infection$78,500
R03 · FY2023 · AR · contact PI
Engineering recombinant lubricin to combat orthopedic infection$78,500
R03 · FY2022 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$204,434
K08 · FY2021 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$204,434
K08 · FY2020 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$1,000
K08 · FY2020 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$204,434
K08 · FY2019 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$204,434
K08 · FY2018 · AR · contact PI
Glycans in joint disease and glycosylated lubricin mimetics for osteoarthritis therapy$204,434
K08 · FY2017 · AR · contact PI